| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/21/2009 | US20090130681 21132, a Human G-protein coupled receptor family member and uses therefor |
| 05/21/2009 | US20090130239 Method for preventing or treating edema or dermatitis using glehnia littoralis fr. schmidt et miquel extract |
| 05/21/2009 | US20090130147 Capsular polysaccharide solubilisation and combination vaccines |
| 05/21/2009 | US20090130146 Combination vaccine |
| 05/21/2009 | US20090130141 Compositions and methods for stimulating an immune response against infectious agents |
| 05/21/2009 | US20090130140 Capsular Polysaccharide Solubilisation and Combination Vaccines |
| 05/21/2009 | US20090130126 Dna expression vectors |
| 05/21/2009 | US20090130112 Spatial for altering cell proliferation |
| 05/21/2009 | US20090130109 DCL-1 and uses thereof |
| 05/21/2009 | US20090130095 Composition comprising tumor necrosis factor (CD40) specific immunoglobulin for treatment and prevention of autoimmune diseases |
| 05/21/2009 | US20090130089 Anti-cd20 antibodies and methods of use |
| 05/21/2009 | US20090130072 Use of Lactobacillus Kefiranofaciens as a Probiotic and a Synbiotic |
| 05/21/2009 | US20090130067 Cell Population Having Immunoregulatory Activity, Method for Isolation and Uses |
| 05/20/2009 | EP2060634A1 Structure protein of adeno-associated virus with amended antigenity, production and application thereof |
| 05/20/2009 | EP2060582A1 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions |
| 05/20/2009 | EP2060572A1 Pyrazolopyridine derivative and phosphodiesterase (pde) inhibitor containing the same as active ingredient |
| 05/20/2009 | EP2060563A1 Cyclic aminoalkylcarboxamide derivative |
| 05/20/2009 | EP2060271A1 Liposome and immunostimulating composition comprising the same |
| 05/20/2009 | EP2060258A1 Use of CRTH2 antagonist compounds in therapy |
| 05/20/2009 | EP2060255A2 Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection |
| 05/20/2009 | EP2059534A1 Engineered anti-il-23p19 antibodies |
| 05/20/2009 | EP2059257A2 Use of glycolipids as adjuvants |
| 05/20/2009 | EP1883302A4 Jak kinase inhibitors and their uses |
| 05/20/2009 | EP1835922B1 Combination treatment for multiple sclerosis |
| 05/20/2009 | EP1365760B1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 05/20/2009 | EP1223975B1 MUCOSAL DTPa VACCINES |
| 05/20/2009 | DE60226032T2 Neue imidazolidinderivate, deren herstellung und verwendung als vla4-antagonisten New imidazolidine derivatives, their preparation and use as VLA4 antagonists |
| 05/20/2009 | DE102007054653A1 Use of thiourea derivative to degrade advanced glycation end-products, Maillard-products and Amadori products and to prepare medicament to inhibit skin diseases during diabetes and to treat e.g. cataract, arthritis and Alzheimer's disease |
| 05/20/2009 | CN201239424Y Multifunctional health-care girdle |
| 05/20/2009 | CN101437799A p38 MAP kinase inhibitors |
| 05/20/2009 | CN101437797A Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them |
| 05/20/2009 | CN101437796A Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them |
| 05/20/2009 | CN101437501A Prolongation of survival of an allograft by inhibiting complement activity |
| 05/20/2009 | CN101434661A Lichee polysaccharide, and extracting method and use thereof |
| 05/20/2009 | CN101434650A Bursa pentapeptide, deriving peptide thereof and use thereof |
| 05/20/2009 | CN101434593A Two crystal substances of baicalin, and preparations, pharmaceutical composition and uses thereof |
| 05/20/2009 | CN101433710A Nourishing medicinal liquor |
| 05/20/2009 | CN101433669A Use of pharmaceutical composition in preparing medicament for preventing and treating allergic diseases |
| 05/20/2009 | CN101433668A Prescription of wine for beauty treatment and face nursing and production method |
| 05/20/2009 | CN101433632A Antiradiation composition for improving immunity |
| 05/20/2009 | CN101433631A Antiradiation composition for improving immunity and preparation method thereof |
| 05/20/2009 | CN101433630A Antiradiation composition for improving immunity and preparation method thereof |
| 05/20/2009 | CN101433626A Antiradiation composition for improving immunity |
| 05/20/2009 | CN101433625A Compound trepang glycopeptide oral liquid |
| 05/20/2009 | CN101433620A Longan water-soluble active substance as well as extraction method and use thereof |
| 05/20/2009 | CN101433609A Use of pharmaceutical composition in preparing medicament for preventing and treating allergic diseases |
| 05/20/2009 | CN101433591A Method for preparing composite glycopeptide of Ficus carica |
| 05/20/2009 | CN101433556A Health product composition containing placenta component and preparation method |
| 05/20/2009 | CN101433316A Health capsule and method of processing the same |
| 05/20/2009 | CN101433241A Formula bovine colostrum |
| 05/20/2009 | CN101433160A Method for cultivating medicinal morel and products produced thereby |
| 05/20/2009 | CN100489098C Goose B lymphocyte stimulating factor CDNA, and its cloning method and recombinant use |
| 05/20/2009 | CN100488979C Glycyrrhetinic acid-30-acylamide derivatives and its use |
| 05/20/2009 | CN100488975C N-alkylated 1,6-bideoxyazaglucide compound, its synthesis method and uses |
| 05/20/2009 | CN100488948C N-substituted indole-3-acetaldehyde amide compound with anti-asthma, anti-amaphylactic and immunosupression/immunoregulation action |
| 05/20/2009 | CN100488946C Salts of guanidine derivatives and its pharmaceutical preparations composition |
| 05/20/2009 | CN100488561C Method for preparing interferon long-acting injection microsphere preparation |
| 05/20/2009 | CN100488533C An herbal composition for the treatment and remedy of bronchial respiratory difficulties |
| 05/20/2009 | CN100488520C Medicine for curing allergic colitis |
| 05/20/2009 | CN100488506C 5-membered heterocycle derivatives, production thereof and use as medicaments |
| 05/20/2009 | CN100488501C Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyper-permeability or undesired permeability |
| 05/20/2009 | CN100488500C Use of COX-2 inhibitors for preventing immunodeficiency |
| 05/19/2009 | US7534897 Indole arylsulfonaimide compounds exhibiting PGD 2 receptor antagonism |
| 05/19/2009 | US7534884 Preparation of pharmaceutical salts |
| 05/19/2009 | US7534863 Leucine-based motifs and enhanced biological persistence of clostridial neurotoxins |
| 05/19/2009 | US7534808 Indolylmaleimide derivatives |
| 05/19/2009 | US7534800 pyrrolo[2,3-b]pyridine derivatives; treatment of neurodegenerative disorders related to apoptosis and/or inflammation; compound prepared by condensation, halogenation, hydrogenation, using silan protected drivatives |
| 05/19/2009 | US7534799 Pyridomorphinans, thienomorphinans and use thereof |
| 05/19/2009 | US7534790 Aminocyclohexyl ether compounds such as trans-[2-(4-morpholinyl)-1-(2-naphthenethoxy)]cyclohexane; arrhythmia, analgesia and local anesthesia |
| 05/19/2009 | US7534776 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 05/19/2009 | US7534440 Fusion molecules and methods for treatment of immune diseases |
| 05/19/2009 | US7534439 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 05/19/2009 | US7534427 Predosing with non-radiolabeled antibody not performed |
| 05/19/2009 | CA2463947C Montelukast granule formulation |
| 05/19/2009 | CA2395969C Novel tetrahydropyridines, method for the preparation thereof and pharmaceutical compositions containing them |
| 05/19/2009 | CA2379435C Topical azathioprine for the treatment of oral autoimmune diseases |
| 05/19/2009 | CA2364801C Pyridazin-3-one derivatives and medicines containing the same |
| 05/19/2009 | CA2247071C Dna vaccination for induction of suppressive t cell response |
| 05/19/2009 | CA2209167C Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 05/14/2009 | WO2009061807A2 Activin receptor-like kinase-i antagonist compositions and methods of use |
| 05/14/2009 | WO2009061445A2 Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction |
| 05/14/2009 | WO2009060445A1 Synthetic sphingolipid analogs |
| 05/14/2009 | WO2009060281A2 Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties |
| 05/14/2009 | WO2009060160A1 P38 map kinase inhibitors |
| 05/14/2009 | WO2009060073A1 Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates |
| 05/14/2009 | WO2009040083A3 Use of a peptide as a therapeutic agent |
| 05/14/2009 | WO2009040047A3 Therapeutic uses of ghrelin and combinations with stresscopin |
| 05/14/2009 | WO2009040033A3 Use of a peptide as a therapeutic agent |
| 05/14/2009 | WO2009040019A3 Use of a peptide as a therapeutic agent |
| 05/14/2009 | WO2009039986A3 Use of the peptide asn-asp-asp-cys-glu- leu-cys-val-asn-val-ala-cys-thr-gly-cys-leu alone or in combination with the peptide thr-thr-ser-gln-val- arg-pro-αrg as a therapeutic agent |
| 05/14/2009 | WO2009033807A3 Therapeutic uses of b-type natriuretic peptide and human growth hormone 1-43 |
| 05/14/2009 | WO2009033804A3 Use of gamma- endorphin as a therapeutic agent |
| 05/14/2009 | WO2009033803A3 Use of the pentapeptide drlds and gamma-endorphin as therapeutic agents |
| 05/14/2009 | WO2009033799A3 Use of a peptide as a therapeutic agent |
| 05/14/2009 | WO2009033754A8 Use of a peptide as a therapeutic agent |
| 05/14/2009 | WO2008118823A3 Compositions and methods for inhibition of the jak pathway |
| 05/14/2009 | WO2008074803A8 4-benzyl-l ( 2h) -phthalazinones as h1 receptor antagonists |
| 05/14/2009 | WO2008049123A8 2,4-pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases |
| 05/14/2009 | WO2008041236A3 Composition comprising crustacean gastrolith components, calcium carbonate and its use |
| 05/14/2009 | WO2006123230A8 Compositions for antigen-specific induction of immuno-tolerance via oral immunization |